Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-Label, Dose-Finding Study Of ASN007 In Patients With Advanced Solid Tumors

NCT03415126 is registered in ClinicalTrials.gov with Asana BioSciences as lead sponsor.

NCT NCT03415126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-Label, Dose-Finding Study Of ASN007 In Patients With Advanced Solid Tumors
Lead sponsor
Asana BioSciences
Phase
Phase 1
Overall status
Completed
Start date
January 19, 2018
Completion date
June 30, 2020
Enrollment
49 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, colon cancer, colon cancer liver metastasis, colonic neoplasms, malignancy, metastatic cancer, metastatic colon cancer, metastatic lung cancer, metastatic melanoma, metastatic nonsmall cell lung cancer, metastatic pancreatic cancer, neoplasia, neoplasm, neoplasm metastasis, non small cell lung cancer metastatic, pancreas adenocarcinoma, pancreas cancer, pancreas neoplasm, pancreatic cancer